Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 3
2018 3
2019 3
2020 2
2021 9
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Transposable elements in brain health and disease.
Ahmadi A, De Toma I, Vilor-Tejedor N, Eftekhariyan Ghamsari MR, Sadeghi I. Ahmadi A, et al. Among authors: de toma i. Ageing Res Rev. 2020 Dec;64:101153. doi: 10.1016/j.arr.2020.101153. Epub 2020 Sep 22. Ageing Res Rev. 2020. PMID: 32977057 Review.
The importance of long non-coding RNAs in neuropsychiatric disorders.
Hosseini E, Bagheri-Hosseinabadi Z, De Toma I, Jafarisani M, Sadeghi I. Hosseini E, et al. Among authors: de toma i. Mol Aspects Med. 2019 Dec;70:127-140. doi: 10.1016/j.mam.2019.07.004. Epub 2019 Jul 19. Mol Aspects Med. 2019. PMID: 31319085 Review.
Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders.
Xicota L, De Toma I, Maffioletti E, Pisanu C, Squassina A, Baune BT, Potier MC, Stacey D, Dierssen M; European College of Neuropsychopharmacology (ECNP) Pharmacogenomics & Transcriptomics Thematic Workgroup. Xicota L, et al. Among authors: de toma i. Eur Neuropsychopharmacol. 2022 Jan;54:41-53. doi: 10.1016/j.euroneuro.2021.10.005. Epub 2021 Nov 4. Eur Neuropsychopharmacol. 2022. PMID: 34743061 Review.
Translating molecular advances in Down syndrome and Fragile X syndrome into therapies.
Faundez V, De Toma I, Bardoni B, Bartesaghi R, Nizetic D, de la Torre R, Cohen Kadosh R, Herault Y, Dierssen M, Potier MC; Down Syndrome and Other Genetic Developmental Disorders ECNP Network. Faundez V, et al. Among authors: de toma i. Eur Neuropsychopharmacol. 2018 Jun;28(6):675-690. doi: 10.1016/j.euroneuro.2018.03.006. Epub 2018 Jun 7. Eur Neuropsychopharmacol. 2018. PMID: 29887288 Review.
Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.
Illouz T, Biragyn A, Iulita MF, Flores-Aguilar L, Dierssen M, De Toma I, Antonarakis SE, Yu E, Herault Y, Potier MC, Botté A, Roper R, Sredni B, London J, Mobley W, Strydom A, Okun E. Illouz T, et al. Among authors: de toma i. Front Immunol. 2021 Jun 25;12:621440. doi: 10.3389/fimmu.2021.621440. eCollection 2021. Front Immunol. 2021. PMID: 34248930 Free PMC article. Review.
Specific Susceptibility to COVID-19 in Adults with Down Syndrome.
Illouz T, Biragyn A, Frenkel-Morgenstern M, Weissberg O, Gorohovski A, Merzon E, Green I, Iulita F, Flores-Aguilar L, Dierssen M, De Toma I, Lifshitz H, Antonarakis SE, Yu E, Herault Y, Potier MC, Botté A, Roper R, Sredni B, Sarid R, London J, Mobley W, Strydom A, Okun E. Illouz T, et al. Among authors: de toma i. Neuromolecular Med. 2021 Dec;23(4):561-571. doi: 10.1007/s12017-021-08651-5. Epub 2021 Mar 4. Neuromolecular Med. 2021. PMID: 33660221 Free PMC article.
Intensive assessment of executive functions derived from performance in cognitive training games.
Soldevila-Domenech N, De Toma I, Forcano L, Diaz-Pellicer P, Cuenca-Royo A, Fagundo B, Lorenzo T, Gomis-Gonzalez M, Sánchez-Benavides G, Fauria K, Sastre C, Fernandez De Piérola Í, Molinuevo JL, Verdejo-Garcia A, de la Torre R; PENSA Study Group. Soldevila-Domenech N, et al. Among authors: de toma i. iScience. 2023 May 16;26(6):106886. doi: 10.1016/j.isci.2023.106886. eCollection 2023 Jun 16. iScience. 2023. PMID: 37260752 Free PMC article.
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review.
Pisanu C, Severino G, De Toma I, Dierssen M, Fusar-Poli P, Gennarelli M, Lio P, Maffioletti E, Maron E, Mehta D, Minelli A, Potier MC, Serretti A, Stacey D, van Westrhenen R, Xicota L; European College of Neuropsychopharmacology (ECNP) Pharmacogenomics & Transcriptomics Network; Baune BT, Squassina A. Pisanu C, et al. Among authors: de toma i. Eur Neuropsychopharmacol. 2022 Feb;55:112-157. doi: 10.1016/j.euroneuro.2021.12.005. Epub 2022 Jan 8. Eur Neuropsychopharmacol. 2022. PMID: 35016057
25 results